Abbott Laboratories
(ABT-NYSE)
DRUGS - Drug Manufacturers - Major
Stock report updated on 01/20/2012
- ABT is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- ABT is one of this week's least volatile stocks in the S&P-100 with an estimated annualized standard deviation of 13.8%.
- Volatility is forecast to fall over the next month.
- Price broke above prior resistance level - a short-term bullish signal.
| Closing price: |
$55.76 |
| Support price level: |
$55.16 |
| Resistance price level: |
N/A |
| Relative strength index (14-day RSI): |
42.8 |
| Beta: |
0.45 |
52-Week Range
| Low |
High |
Price as % of Range |
| $45.16 |
$56.72 |
92.5% |
Moving Averages
| 200 day |
50 day |
20 day |
10 day |
| $52.54 |
$54.72 |
$55.87 |
$55.61 |
Volatility (annualized std. dev.)
Historical
(5 year) |
Last month |
Current estimate |
Next month forecast |
| 22.2% |
16.2% |
13.8% |
18.1% |
Value at Risk
There is an estimated 5% probability that the stock price of Abbott Laboratories will fall by more than:
- 3.7% in the next week.
- 10.2% in the next month.
- 34.7% in the next year.
Company News for Abbott Laboratories
Google Finance |
MSN Money |
Reuters
Reports for Other Stocks
